IFP Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$73.9K Buy
3,426
+14
+0.4% +$302 ﹤0.01% 1830
2025
Q1
$56.7K Sell
3,412
-646
-16% -$10.7K ﹤0.01% 1843
2024
Q4
$74.5K Buy
4,058
+498
+14% +$9.14K ﹤0.01% 1624
2024
Q3
$54.7K Buy
3,560
+879
+33% +$13.5K ﹤0.01% 1693
2024
Q2
$43.6K Buy
2,681
+1,231
+85% +$20K ﹤0.01% 1739
2024
Q1
$26.8K Buy
+1,450
New +$26.8K ﹤0.01% 1846
2023
Q2
Sell
-1,500
Closed -$27.5K 3441
2023
Q1
$27.5K Sell
1,500
-500
-25% -$9.17K ﹤0.01% 1876
2022
Q4
$37K Sell
2,000
-27
-1% -$500 ﹤0.01% 2434
2022
Q3
$38K Buy
2,027
+1,500
+285% +$28.1K ﹤0.01% 2571
2022
Q2
$10K Hold
527
﹤0.01% 3373
2022
Q1
$10K Buy
+527
New +$10K ﹤0.01% 3373
2021
Q3
Sell
-152
Closed -$4K 3297
2021
Q2
$4K Sell
152
-148
-49% -$3.9K ﹤0.01% 2505
2021
Q1
$8K Buy
300
+100
+50% +$2.67K ﹤0.01% 2188
2020
Q4
$11K Buy
+200
New +$11K ﹤0.01% 2018
2020
Q3
Sell
-22
Closed -$1K 2788
2020
Q2
$1K Buy
+22
New +$1K ﹤0.01% 2461
2020
Q1
Hold
0
2695
2019
Q4
Hold
0
2810
2019
Q3
Hold
0
3039
2019
Q1
Sell
-1,186
Closed -$19K 2346
2018
Q4
$19K Buy
1,186
+750
+172% +$12K ﹤0.01% 2127
2018
Q3
$9K Buy
436
+118
+37% +$2.44K ﹤0.01% 2853
2018
Q2
$5K Sell
318
-518
-62% -$8.15K ﹤0.01% 3174
2018
Q1
$25K Hold
836
﹤0.01% 2236
2017
Q4
$25K Sell
836
-1,682
-67% -$50.3K ﹤0.01% 2232
2017
Q3
$95K Buy
2,518
+475
+23% +$17.9K ﹤0.01% 1578
2017
Q2
$57K Sell
2,043
-975
-32% -$27.2K ﹤0.01% 1862
2017
Q1
$104K Sell
3,018
-3,091
-51% -$107K ﹤0.01% 1463
2016
Q4
$176K Sell
6,109
-2,688
-31% -$77.4K 0.01% 1114
2016
Q3
$280K Buy
8,797
+2,350
+36% +$74.8K 0.01% 839
2016
Q2
$209K Buy
+6,447
New +$209K 0.01% 944
2016
Q1
Sell
-4,249
Closed -$151K 2344
2015
Q4
$151K Buy
+4,249
New +$151K 0.01% 963